Meitav Investment House’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,318
Closed -$1.66M 421
2021
Q1
$1.66M Sell
4,318
-25
-0.6% -$11.3K 0.05% 176
2020
Q4
$1.24M Hold
4,343
0.05% 158
2020
Q3
$1.46M Buy
4,343
+48
+1% +$13K 0.07% 128
2020
Q2
$545K Buy
4,295
+2,985
+228% +$397K 0.03% 209
2020
Q1
$178K Buy
+1,310
New +$194K 0.01% 344
2019
Q4
Sell
-5,605
Closed -$718K 436
2019
Q3
$718K Hold
5,605
0.05% 200
2019
Q2
$1.04M Hold
5,605
0.07% 158
2019
Q1
$1.65M Sell
5,605
-1
-0% -$297 0.09% 130
2018
Q4
$1.74M Hold
5,606
0.11% 103
2018
Q3
$2.02M Buy
+5,606
New +$2.57M 0.1% 132

Other funds holding DRIO

Meitav Investment House's DRIO Position: Q2 2021 in Review

Meitav Investment House sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 4,318 shares — an estimated $1.66M sold.

Meitav Investment House first reported a position in DRIO in Q3 2018 and held it in 10 quarters. The position peaked at $2.02M in Q3 2018. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

  • Meitav Investment House reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
  • Meitav Investment House sold 4,318 DarioHealth shares in Q2 2021, an estimated $1.66M.
  • Meitav Investment House first reported a position in DarioHealth in Q3 2018 and held it in 10 quarters.
  • Meitav Investment House's DarioHealth position peaked at $2.02M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on Meitav Investment House's 13F filing for Q2 2021, filed 5 Aug 2021.